Stockreport

AgeX Therapeutics Researchers Publish Paper on the Age Reprogramming of Super-Centenarian Cells

AgeX Therapeutics, Inc.  (AGE) 
PDF Cells of 114-year-old converted to young pluripotent stem cells Evidence of reversal of the telomere aging clock in a supercentenarian Supports hypothesis of no upper ag [Read more]